Misplaced Pages

TDIQ

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Chemical compound Pharmaceutical compound
TDIQ
Identifiers
IUPAC name
  • 5,6,7,8-Tetrahydro-dioxoloisoquinoline
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC10H11NO2
Molar mass177.203 g·mol
3D model (JSmol)
SMILES
  • c23OCOc2cc1CCNCc1c3
InChI
  • InChI=1S/C10H11NO2/c1-2-11-5-8-4-10-9(3-7(1)8)12-6-13-10/h3-4,11H,1-2,5-6H2
  • Key:JHLDJOBIUVJSTG-UHFFFAOYSA-N
  (verify)

TDIQ (also known as 6,7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline or MDTHIQ) is a drug used in scientific research, which has anxiolytic and anorectic effects in animals. It has an unusual effects profile in animals, with the effects generalising to cocaine and partially to MDMA and ephedrine, but the effects did not generalise to amphetamine and TDIQ does not have any stimulant effects. It is thought these effects are mediated via a partial agonist action at Alpha-2 adrenergic receptors, and TDIQ has been suggested as a possible drug for the treatment of cocaine dependence.

See also

References

  1. Young R, Rothman RB, Rangisetty JB, Partilla JS, Dukat M, Glennon RA (May 2006). "TDIQ (5,6,7,8-tetrahydro-1,3-dioxoloisoquinoline) inhibits the consumption of "snacks" in mice". Pharmacology Biochemistry and Behavior. 84 (1): 74–83. doi:10.1016/j.pbb.2006.04.007. PMID 16750261. S2CID 22564648.
  2. Young R, Batkai S, Dukat M, Glennon RA (May 2006). "TDIQ (5,6,7,8-tetrahydro-1,3-dioxoloisoquinoline) exhibits anxiolytic-like activity in a marble-burying assay in mice". Pharmacology Biochemistry and Behavior. 84 (1): 62–73. doi:10.1016/j.pbb.2006.04.006. PMID 16750844. S2CID 12307882.
  3. Young R, Glennon RA (2002). "The stimulus effect of 5,6,7,8-tetrahydro-1,3-dioxoloisoquinoline is similar to that of cocaine but different from that of amphetamine". Pharmacology Biochemistry and Behavior. 71 (1–2): 205–13. CiteSeerX 10.1.1.670.8659. doi:10.1016/S0091-3057(01)00666-9. PMID 11812524. S2CID 16553365.
  4. Glennon RA, Young R, Rangisetty JB (May 2002). "Further characterization of the stimulus properties of 5,6,7,8-tetrahydro-1,3-dioxoloisoquinoline". Pharmacology Biochemistry and Behavior. 72 (1–2): 379–87. doi:10.1016/S0091-3057(01)00768-7. PMID 11900809. S2CID 33311107.
  5. Young R (2007). "TDIQ (5,6,7,8-tetrahydro-1,3-dioxolo [4,5-g]isoquinoline): discovery, pharmacological effects, and therapeutic potential". CNS Drug Reviews. 13 (4): 405–22. doi:10.1111/j.1527-3458.2007.00022.x. PMC 6494129. PMID 18078426.
Adrenergic receptor modulators
α1
Agonists
Antagonists
α2
Agonists
Antagonists
β
Agonists
Antagonists
Stub icon

This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it.

Categories:
TDIQ Add topic